Home Newsfeeds Raymond James Downgrades Centerspace to Underperform

Raymond James Downgrades Centerspace to Underperform

Raymond James analyst Buck Horne downgrades Centerspace (NYSE:CSR) from Market Perform to Underperform.

byBenzinga Newsdesk

November 23, 2022

1 minute read

Raymond James analyst Buck Horne downgrades Centerspace (NYSE:CSR) from Market Perform to Underperform.

Mizuho Initiates Coverage On Glaukos with Neutral Rating, Announces Price Target of $48

By Benzinga Newsdesk

December 22, 7:59 AM

Mizuho analyst Anthony Petrone initiates coverage on Glaukos (NYSE:GKOS) with a Neutral rating and announces Price Target of $48.

GKOS

Analyst Ratings

Expert Ratings for Equinix

By Benzinga Insights

March 27, 9:00 AM

Over the past 3 months, 8 analysts have published their opinion on Equinix (NASDAQ:EQIX) stock. These analysts are…

EQIX

News

Sagimet Biosciences to Host Virtual Investor and Analyst Day on Inhibiting Fatty Acid Synthase (FASN) to Reduce Liver Fat, Inflammation and Fibrosis in MASH on May 23, 2024

By Benzinga Newsdesk

May 16, 8:02 AM

Sagimet Biosciences Inc. ((Sagimet, NASDAQ:SGMT), a clinical-stage biopharmaceutical company developing novel fatty acid synthase (FASN) inhibitors designed to target dysfunctional metabolic and fibrotic pathways, today

SGMT

MultiMetaVerse Announces Term Sheet Signed To Acquire Equity Stake In Taomee; Shares Move Higher

By Happy Mohamed

June 2, 8:39 AM

MultiMetaVerse Holdings Limited ("MMV" or the "Company"), an animation and entertainment company for young consumers in China, announced today that it has entered into a non-binding term sheet

MMV

Raymond James Downgrades Centerspace to Underperform

Related Posts

Mizuho Initiates Coverage On Glaukos with Neutral Rating, Announces Price Target of $48

Expert Ratings for Equinix

Sagimet Biosciences to Host Virtual Investor and Analyst Day on Inhibiting Fatty Acid Synthase (FASN) to Reduce Liver Fat, Inflammation and Fibrosis in MASH on May 23, 2024

MultiMetaVerse Announces Term Sheet Signed To Acquire Equity Stake In Taomee; Shares Move Higher